Press Releases Bavarian Nordic A/S

Equities

BAVA

DK0015998017

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:59 2024-04-29 EDT			5-day change	1st Jan Change
152.8 ^DKK	+2.62%		+1.77%	-13.92%

05:40pm	Bavarian Nordic Starts US Rolling Submission Process for Chikungunya Vaccine Candidate	MT
03-13	Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate	09:04am	GL
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS	04-23	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	04-22	GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S	04-16	GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine	04-04	AQ
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	04-02	GL
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.	04-02	AQ
Bavarian Nordic A/S : Notice Convening Annual General Meeting	03-21	PU
Bavarian Nordic A/S – Notice Convening Annual General Meeting	03-21	GL
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland	03-13	GL
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH	03-13	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	03-12	GL
REPORT OF TRANSACTIONS OF SHARES AND RELATED SECURITIES OF BAVARIAN NORDIC BY PERSONS HOLDING MANAGERIAL RESPONSIBILITIES AND OR PERSONS, COMPANIES CLOSELY ASSOCIATED WITH SUCH	03-07	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	03-06	GL
Bavarian Nordic Publishes Annual Report 2023	03-06	GL
BAVARIAN NORDIC'S CHIKUNGUNYA VACCINE CANDIDATE GRANTED ACCELERATED ASSESSMENT BY EUROPEAN MEDICINES AGENCY	02-26	AQ
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency	02-23	GL
Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency	02-23	AQ
ExpreS2ion's Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic's Clinical Phase III Study for the COVID-19 Vaccine	02-21	AQ
Bavarian Nordic delivered record financial results in 2023	02-21	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bavarian Nordic A/S

Equities

BAVA

DK0015998017

Press Releases

Filters